# BioCardia, Inc.: Form 8-K, filed May 1, 2023

- Company: [BioCardia, Inc.](/companies/bcda.md) (CIK 925741)
- Form: 8-K
- Filed: 2023-05-01
- Accepted by EDGAR: May 1, 2023, 16:34 ET
- Period: 2023-04-30
- Accession: 0001437749-23-011915
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/925741/000143774923011915/bcda20230425d_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/925741/000143774923011915/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/925741/000143774923011915/bcda20230425d_8k.htm

Filed May 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001437749-23-011915. Last ingested by Listed: Nov 6, 2026, 12:20 ET. No prices; not investment advice.